{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:58:25Z","timestamp":1790614705175,"version":"4.1.0"},"reference-count":27,"publisher":"Pan American Health Organization","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,11]]},"abstract":"<title>ABSTRACT<\/title>\n                  <sec>\n                    <title>Objective.<\/title>\n                    <p>To describe blood pressure trajectories and hypertension control among patients enrolled in the HEARTS program in south-west Trinidad.<\/p>\n                  <\/sec>\n                  <sec>\n                    <title>Methods.<\/title>\n                    <p>This retrospective longitudinal cohort study used routinely collected HEARTS program data from 31 public primary health centers in the South-West Regional Health Authority, Trinidad and Tobago. Eligible patients initiated HEARTS between 1 April and 31 October 2023, with a baseline program record and at least one follow-up blood pressure measurement. Follow-up was categorized as month-1 to month-5. McNemar\u2019s test assessed paired baseline versus month-5 control status; linear and generalized linear mixed-effects models assessed blood pressure trajectories and hypertension control.<\/p>\n                  <\/sec>\n                  <sec>\n                    <title>Results.<\/title>\n                    <p>\n                      The analytic cohort included 548 patients; 63.3% were female and mean age was 61.4 \u00b1 11.0 years. At baseline, 80.7% had uncontrolled hypertension. Mean baseline systolic blood pressure was 155 \u00b1 22 mmHg and diastolic 86 \u00b1 14 mmHg. Among 502 patients with paired baseline and month-5 data, more patients transitioned from uncontrolled to controlled hypertension than the reverse (70 vs 41; McNemar OR 1.71, 95% CI [1.16, 2.51],\n                      <italic>p<\/italic>\n                      = 0.006). In mixed-effects analyses, month was associated with lower systolic blood pressure. Odds of hypertension control were higher at month-2 and month-5 relative to baseline, while higher body mass index (BMI) was associated with lower odds of control.\n                    <\/p>\n                  <\/sec>\n                  <sec>\n                    <title>Conclusions.<\/title>\n                    <p>Among patients with available follow-up data, the HEARTS program was associated with improved hypertension control in routine primary care, while higher BMI was associated with lower odds of control. These findings should be interpreted as observational program outcomes rather than evidence of a causal program effect.<\/p>\n                  <\/sec>","DOI":"10.26633\/rpsp.2026.87","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:13:16Z","timestamp":1789135996000},"page":"1","source":"Crossref","is-referenced-by-count":1,"title":["Hypertension control within the HEARTS program of south-west Trinidad: a longitudinal mixed-effects analysis"],"prefix":"10.26633","volume":"50","author":[{"given":"Gavaskar","family":"Ramnanansingh","sequence":"first","affiliation":[{"name":"The University of the West Indies, St. Augustine, Trinidad and Tobago"},{"name":"gavaskar@ramnanansingh.com"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia Alessandra","family":"Hankey","sequence":"additional","affiliation":[{"name":"South-West Regional Health Authority, San Fernando, Trinidad and Tobago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Chang","sequence":"additional","affiliation":[{"name":"South-West Regional Health Authority, San Fernando, Trinidad and Tobago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Shirley","family":"Daniel","sequence":"additional","affiliation":[{"name":"The University of the West Indies, St. Augustine, Trinidad and Tobago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Lakhan","sequence":"additional","affiliation":[{"name":"The University of the West Indies, St. Augustine, Trinidad and Tobago"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11167","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022;80(25):2361\u20132371. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.005.","DOI":"10.1016\/j.jacc.2022.11.005"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982\u20133021. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.010.","DOI":"10.1016\/j.jacc.2020.11.021"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Di Cesare M, Perel P, Taylor S, Kabudula C, Bixby H, Gaziano TA, et al. The heart of the world. Glob Heart. 2024;19(1):11. https:\/\/doi.org\/10.5334\/gh.1288.","DOI":"10.5334\/gh.1288"},{"key":"ref4","unstructured":"World Health Organization. Global report on hypertension: the race against a silent killer. Geneva: WHO; 2023. Available from: https:\/\/iris.who.int\/handle\/10665\/372896."},{"key":"ref5","unstructured":"United Nations Department of Economic and Social Affairs. The Sustainable Development Goals report 2025. New York: United Nations; 2025. Available from: https:\/\/unstats.un.org\/sdgs\/report\/2025\/The-Sustainable-Development-Goals-Report-2025.pdf."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9.","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957\u2013980. https:\/\/doi.org\/10.1016\/S0140-6736(21)01330-1.","DOI":"10.1016\/S0140-6736(21)01330-1"},{"key":"ref8","unstructured":"World Health Organization. Technical package for cardiovascular disease management in primary health care: implementation guide. Geneva: WHO; 2018. Available from: https:\/\/iris.who.int\/handle\/10665\/275728."},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Ordunez P, Campbell NRC, Giraldo Arcila GP, Angell SY, Lombardi C, Brettler JW, et al. HEARTS in the Americas: innovations for improving hypertension and cardiovascular disease risk management in primary care. Rev Panam Salud Publica. 2022;46:e96. https:\/\/doi.org\/10.26633\/RPSP.2022.96.","DOI":"10.26633\/RPSP.2022.96"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Ordunez P, Campbell NRC, DiPette DJ, Jaffe MG, Rosende A, Martinez R, et al. HEARTS in the Americas: targeting health system change to improve population hypertension control. Curr Hypertens Rep. 2024;26(4):141\u2013156. https:\/\/doi.org\/10.1007\/s11906-023-01286-w.","DOI":"10.1007\/s11906-023-01286-w"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Doon R, Malcolm T, Lewis Y, Holder L, Gulston L, Hamid A, et al. Improving cardiovascular health with the patient-centered, integrated primary care HEARTS model in Trinidad and Tobago. Rev Panam Salud Publica. 2022;46:e169. https:\/\/doi.org\/10.26633\/RPSP.2022.169.","DOI":"10.26633\/RPSP.2022.169"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Mendoza Z, Khan R, Maharaj RG, Motilal MS. Hypertension control applying the HEARTS in the Americas protocol in Trinidad: A cross-sectional study. Rev Panam Salud Publica. 2025;49:e123. https:\/\/doi.org\/10.26633\/RPSP.2025.123.","DOI":"10.26633\/RPSP.2025.123"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Londo\u00f1o E, Gupta R, Van der Stuyft P, Heine M, Giraldo G, Ku GM, et al. HEARTS quality: a policy framework to strengthen hypertension and cardiovascular risk management in primary healthcare\u2014insights from HEARTS in the Americas. Lancet Reg Health Am. 2025;53:101311. https:\/\/doi.org\/10.1016\/j.lana.2025.101311.","DOI":"10.1016\/j.lana.2025.101311"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Vald\u00e9s Gonz\u00e1lez Y, Campbell NRC, Pons Barrera E, Calder\u00f3n Mart\u00ednez M, P\u00e9rez Carrera A, Morales Rigau JM, et al. Implementation of a community\u2010based hypertension control program in Matanzas, Cuba. J Clin Hypertens (Greenwich). 2020;22(2):142\u2013149. https:\/\/doi.org\/10.1111\/jch.13814.","DOI":"10.1111\/jch.13814"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Rosende A, DiPette DJ, Martinez R, Brettler JW, Rodriguez G, Zuniga E, et al. HEARTS in the Americas clinical pathway. Strengthening the decision support system to improve hypertension and cardiovascular disease risk management in primary care settings. Front Cardiovasc Med. 2023;10:1102482. https:\/\/doi.org\/10.3389\/fcvm.2023.1102482.","DOI":"10.3389\/fcvm.2023.1102482"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u20133104. https:\/\/doi.org\/10.1093\/eurheartj\/ehy339.","DOI":"10.1093\/eurheartj\/ehy339"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Abreu APD. Hypertension in Latin America and the Caribbean: an analysis of recent progress and remaining challenges. J Bras Nefrol. 2025;47(3):e20240245. https:\/\/doi.org\/10.1590\/2175-8239-jbn-2024-0245en.","DOI":"10.1590\/2175-8239-jbn-2024-0245pt"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Downes M, O\u2019Connor M, Olsson CA, Burgner D, Goldfeld S, Spry EA, et al. Causal inference in multi-cohort studies using the target trial framework to identify and minimize sources of bias. Am J Epidemiol. 2025;194(9):2685\u20132697. https:\/\/doi.org\/10.1093\/aje\/kwae405.","DOI":"10.1093\/aje\/kwae405"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Hamrahian SM, Maarouf OH, F\u00fcl\u00f6p T. A critical review of medication adherence in hypertension: barriers and facilitators clinicians should consider. Patient Prefer Adherence. 2022;16:2749\u20132757. https:\/\/doi.org\/10.2147\/PPA.S368784.","DOI":"10.2147\/PPA.S368784"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912\u20134018. https:\/\/doi.org\/10.1093\/eurheartj\/ehae178.","DOI":"10.1093\/eurheartj\/ehae178"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Mohl JT, Moreno CA, Sadik K, Singhal M, Rooney A, Ciemins EL. Evaluation of blood pressure control, medication adherence, and therapeutic inertia in US patients with hypertension prescribed multiple antihypertensives. J Am Heart Assoc. 2025;14(12):e034787. https:\/\/doi.org\/10.1161\/JAHA.124.034787.","DOI":"10.1161\/JAHA.124.034787"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Parvanova A, Reseghetti E, Abbate M, Ruggenenti P. Mechanisms and treatment of obesity-related hypertension\u2014Part 1: Mechanisms. Clin Kidney J. 2024;17(1):sfad282. https:\/\/doi.org\/10.1093\/ckj\/sfad282.","DOI":"10.1093\/ckj\/sfad282"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Grassi G, Drager LF. Sympathetic overactivity, hypertension and cardiovascular disease: state of the art. Curr Med Res Opin. 2024;40(sup1):5\u201313. https:\/\/doi.org\/10.1080\/03007995.2024.2305248.","DOI":"10.1080\/03007995.2024.2305248"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Loh HH, Tay SP, Koa AJ, Yong MC, Said A, Chai CS, et al. Hypertension in obstructive sleep apnea: the hidden role of renin\u2013angiotensin\u2013aldosterone system dysregulation. Trop Med Health. 2025;53(1):62. https:\/\/doi.org\/10.1186\/s41182-025-00742-4.","DOI":"10.1186\/s41182-025-00742-4"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Charchar FJ, Prestes PR, Mills C, Ching SM, Neupane D, Marques FZ, et al. Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension. J Hypertens. 2024;42(1):23\u201349. https:\/\/doi.org\/10.1097\/HJH.0000000000003563.","DOI":"10.1097\/HJH.0000000000003563"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Yao T, Hu Q, Miao D, Xia Z, Li M, Wang X, et al. The effects of multimodal lifestyle interventions on blood pressure, body weight, and waist circumference in hypertensive patients: a network meta-analysis. Front Public Health. 2026;14:1720695. https:\/\/doi.org\/10.3389\/fpubh.2026.1720695.","DOI":"10.3389\/fpubh.2026.1720695"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Ordunez P, Rosende A, Brettler J, Londono E, Van Der Stuyft P, Martinez-Piedra R, et al. Readiness to deliver integrated cardiovascular, kidney and metabolic care in primary healthcare: phase II of HEARTS 2.0 in 26 countries in the Americas. BMJ Glob Health. 2026;11(1):e021298. https:\/\/doi.org\/10.1136\/bmjgh-2025-021298.","DOI":"10.1136\/bmjgh-2025-021298"}],"container-title":["Revista Panamericana de Salud P\u00fablica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iris.paho.org\/bitstreams\/2f34c899-3b3f-4fdd-8a04-e730d4dd1d7e\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:13:27Z","timestamp":1789136007000},"score":1,"resource":{"primary":{"URL":"https:\/\/iris.paho.org\/handle\/10665.2\/72227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":27,"alternative-id":["RPSP.2026.87"],"URL":"https:\/\/doi.org\/10.26633\/rpsp.2026.87","relation":{},"ISSN":["1020-4989","1680-5348"],"issn-type":[{"value":"1020-4989","type":"print"},{"value":"1680-5348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}